Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 83
Filter
1.
HNO ; 56(6): 651-7; quiz 658, 2008 Jun.
Article in German | MEDLINE | ID: mdl-18483716

ABSTRACT

Tympanosclerosis is a scarring process with a remarkable variability in its localization within the middle ear. It can lead to conductive hearing loss in many cases. It is usually caused by recurrent chronic inflammation of the middle ear. It is generally accepted that functionally relevant tympanosclerotic findings of the middle ear structures should be treated by surgery. Depending on the extent of the surgical resection, the tympanic membrane and the ossicular chain must be reconstructed individually. In cases of isolated myringosclerosis with no hearing loss, no surgery is required. When the ossicular chain is affected by the sclerosis, sound conduction can often be restored only by interposition of grafts. Stapes footplate fixation can be treated by a stapesplasty. Tympanosclerosis of the oval window combined with other chronic inflammation usually requires two-stage surgery. Tympanosclerotic findings without any clinical symptoms should not be removed. The fitting of conventional or implantable hearing aids is the only treatment if chain reconstruction fails or is impossible.


Subject(s)
Hearing Aids , Otosclerosis/pathology , Otosclerosis/surgery , Tympanic Membrane/pathology , Tympanic Membrane/surgery , Tympanoplasty/methods , Humans , Otosclerosis/rehabilitation , Plastic Surgery Procedures/methods , Sclerosis
2.
Laryngorhinootologie ; 87(3): 181-5, 2008 Mar.
Article in German | MEDLINE | ID: mdl-18098102

ABSTRACT

The effectiveness and safety of angiographic embolization was investigated as a preliminary step prior to surgical excision of glomus tumours in the head and neck region. Embolization was performed in 54 patients presenting with a total of 58 chemodectomas, jugular (n=30), tympanicum (n=24) and caroticum (n=4) between the years 1988 and 2006. Embolization was considered successful if complete occlusion of all tumor-feeding vessels was achieved. The procedure was performed using polyvinylalcohol particles and microcoils and lasted for a median duration of 159 minutes. Complete tumor embolization was achieved in 72 % of patients. In 23%, it was partly successful and in 4% it was unsuccessful. 16% of patients experienced minor events during the procedure including hypotension, bradycardia, and vertigo. Following embolization, almost all patients (98%) had their tumour completely excised. Although the majority experienced minor postoperative complications (69%), one patient developed meningitis. There were no reported deaths. Angiographic embolization of glomus tumours in the head and neck before definitive excision can be safe and effective, resulting in an improved surgical outcome and tumour resectability.


Subject(s)
Embolization, Therapeutic , Glomus Tumor/blood supply , Glomus Tumor/surgery , Neoadjuvant Therapy , Otorhinolaryngologic Neoplasms/blood supply , Otorhinolaryngologic Neoplasms/surgery , Adult , Aged , Angiography , Carotid Body Tumor/blood supply , Carotid Body Tumor/diagnostic imaging , Carotid Body Tumor/surgery , Female , Glomus Jugulare Tumor/blood supply , Glomus Jugulare Tumor/diagnostic imaging , Glomus Jugulare Tumor/surgery , Glomus Tumor/diagnostic imaging , Glomus Tympanicum Tumor/blood supply , Glomus Tympanicum Tumor/diagnostic imaging , Glomus Tympanicum Tumor/surgery , Hematocrit , Hemoglobinometry , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/blood supply , Neoplasm Recurrence, Local/diagnostic imaging , Neoplasm Recurrence, Local/surgery , Otorhinolaryngologic Neoplasms/diagnostic imaging , Reoperation , Retrospective Studies , Treatment Outcome
3.
Laryngorhinootologie ; 86(1): 15-21, 2007 Jan.
Article in German | MEDLINE | ID: mdl-17283495

ABSTRACT

BACKGROUND: Auditory neuropathy is a disorder characterised by preservation of outer hair cells function with normal otoacoustic emissions (OAEs), but with absent auditory brainstem responses (ABR). Perisynaptic synchronisation disorder is one of the possible pathogenesis underlying auditory neuropathy. In this paper we describe the clinical presentation and audiological findings in pediatric auditory neuropathy and its management. PATIENTS AND METHODS: 9 children with auditory neuropathy could be included in the study. An audiological evaluation was performed in all children including behavioural audiometry, measurement of the OAEs as well as electrocochleography (ECoG) and ABR recordings. Children who failed to get any benefit from conventional amplification received a cochlear implant. Prior to implantation the responses to electrical stimuli were examined with the promontory test and with the electrically evoked ABR. RESULTS: One child showed auditory neuropathy only on one side with normal hearing thresholds on the contralateral ear. Another child had normal hearing thresholds after the follow up period. Four children received a hearing aid. But variable hearing reactions were observed. Thus in three cases a CI is planned. In three children cochlea implantation was done. Following implantation a remarkable improvement in hearing/speech capabilities with the CI compared to conventional hearing aids were observed in all three cases. Beside, these three children developed open set speech discrimination and are using now oral language for communication. CONCLUSIONS: Auditory neuropathy is a disorder which presents with different clinical and audiological findings. Thus the management of this disorder must be an individual one. In light of our findings we support the use of cochlear implants as an option for children with auditory neuropathy in cases where conventional amplification does not work sufficiently.


Subject(s)
Cochlear Implantation , Cochlear Nerve/physiopathology , Hearing Loss, Sensorineural/rehabilitation , Vestibulocochlear Nerve Diseases/rehabilitation , Audiometry, Evoked Response , Audiometry, Speech , Auditory Threshold/physiology , Brain Stem/physiopathology , Child, Preschool , Evoked Potentials, Auditory, Brain Stem/physiology , Female , Follow-Up Studies , Hair Cells, Auditory, Outer/physiopathology , Hearing Loss, Sensorineural/diagnosis , Hearing Loss, Sensorineural/physiopathology , Humans , Infant , Infant, Newborn , Male , Otoacoustic Emissions, Spontaneous/physiology , Speech Discrimination Tests , Vestibulocochlear Nerve Diseases/diagnosis , Vestibulocochlear Nerve Diseases/physiopathology
4.
J Laryngol Otol ; 120(10): 832-6, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17038229

ABSTRACT

OBJECTIVES: To investigate posterior external ear canal wall reconstruction with a composite cartilage titanium mesh graft in canal wall down tympanoplasty and revision surgery for open mastoids. STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral centre. METHODS: As a preliminary study, 15 selected patients underwent reconstruction of a posterior ear canal wall defect with titanium mesh. Large defects of the posterior external auditory canal wall, resulting from canal wall down tympanoplasty or present in revision surgery, were eliminated by reconstruction using a titanium mesh. The mesh was covered with conchal cartilage and attached to the cortical mastoid bone using 3-mm titanium screws. RESULTS: All patients maintained a normal contour of the external ear canal, without depression, extrusion or infection. There were no failures, based on short-term post-operative controls. However, two procedures had to be revised due to incomplete coverage of the titanium mesh. CONCLUSIONS: This study shows that reconstruction of the posterior ear canal wall with a composite cartilage titanium mesh is a valuable method for preserving the morphology of the external auditory canal in selected cases. Problems occurring in canal wall down tympanomastoidectomy and radical cavities may therefore be avoided. However, long-term results have yet to be evaluated.


Subject(s)
Biocompatible Materials/therapeutic use , Ear Canal/surgery , Ear Cartilage , Mastoid/surgery , Surgical Mesh , Titanium/therapeutic use , Adult , Aged , Aged, 80 and over , Bone Screws , Female , Humans , Male , Middle Aged , Otologic Surgical Procedures , Pilot Projects , Retrospective Studies , Treatment Outcome
8.
HNO ; 51(1): 71-83, 2003 Jan.
Article in German | MEDLINE | ID: mdl-28271197
9.
Article in English | MEDLINE | ID: mdl-12499760

ABSTRACT

Pneumococcal otogenic meningitis is a rare postsurgical complication that can develop following stapedectomy or after cochlear implantation. The bacterial infection can be fatal in some instances. A recent increase in the incidence of otogenic meningitis among cochlear implant wearers is of concern. The majority of meningitis cases are associated with a 2-component electrode manufactured by one cochlear implant company. The device with the added 'positioner' component has been withdrawn from the market (FDA Public Health Web Notification: Cochlear Implant Recipients may be at Greater Risk for Meningitis, Updated: August 29, 2002, www.fda.gov/cdrh/safety/cochlear.html). Not all cases have been subsequent to otitis media and symptoms have developed from less than 24 h up to a few years after implantation. The purpose of this paper is to review and discuss the pathogenesis, pathology/bacteriology and to elaborate on some clinical features of otogenic meningitis in implanted children and adults. Essential aspects of surgery, electrode design, and cochleostomy seal are discussed. Conclusions are drawn from the available data and recommendations are made for good practice in cochlear implantation and follow-up.


Subject(s)
Cochlear Implantation/adverse effects , Cochlear Implants/adverse effects , Meningitis, Bacterial/etiology , Acute Disease , Antibiotic Prophylaxis , Equipment Design , Humans , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/therapy , Otitis Media/complications , Otitis Media/microbiology
10.
Laryngorhinootologie ; 81(11): 815-9, 2002 Nov.
Article in German | MEDLINE | ID: mdl-12458467

ABSTRACT

BACKGROUND: Is scintigraphy in the preoperative diagnosis of cystadenolymphomas dispensable? PATIENTS AND METHODS: In this prospective study 35 patients with tumors of the parotid gland were examined sonographically and scintigraphycally and the results were compared with the histological findings. RESULTS: By means of sonography 88 % (22/25) of the cystadenolymphomas were correctly diagnosed and by means of scintigraphy 80 % (20/25). CONCLUSIONS: Sonography is recommendable as the first-line diagnostic procedure in cystadenolymphomas because it is without radiation load, the free choice of the echographic plane, and it can be repeated as often as desired. Scintigraphy adds in selected cases, as in elder patients, additional informations. The combination of sonography and scintigraphy confirms the presence of cystadenolymphoma and allows the surgeon to make a decision and to avoid surgery especially in high-risk patients.


Subject(s)
Adenolymphoma/diagnosis , Gamma Cameras , Parotid Neoplasms/diagnosis , Ultrasonography , Adenolymphoma/pathology , Adult , Aged , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Parotid Neoplasms/pathology , Prospective Studies , Sensitivity and Specificity , Sodium Pertechnetate Tc 99m
11.
Laryngorhinootologie ; 81(1): 3-7, 2002 Jan.
Article in German | MEDLINE | ID: mdl-11845395

ABSTRACT

Among 4947 children in an outpatients unit for hearing disorders 102 children with Down's syndrome were seen and checked for hearing disorders. 57 had hearing deficiencies, 50 (88 %) conductive hearing loss, 4 (7 %) combined and 3 (5 %) a sensory neural hearing loss. Compared to other publications the number of very young children was very high. 32 patients under two years of age had a hearing disorder. The results underline the necessity of early diagnosis and follow up also in children with normal reactions during the first presentation. Early diagnosis enables early treatment, conservative, surgical or fitting with hearing aids, especially important in the rehabilitation of these children. Hearing aids may be given temporarily imploring communication during the development of the child.


Subject(s)
Down Syndrome/diagnosis , Hearing Loss, Conductive/diagnosis , Hearing Loss, Sensorineural/diagnosis , Child , Child, Preschool , Down Syndrome/rehabilitation , Female , Hearing Loss, Conductive/rehabilitation , Hearing Loss, Sensorineural/rehabilitation , Hearing Tests , Humans , Infant , Language Development Disorders/diagnosis , Language Development Disorders/rehabilitation , Male , Patient Care Team
12.
Article in English | MEDLINE | ID: mdl-11174060

ABSTRACT

A study was conducted to compare the new MED-EL TEMPO+ ear-level speech processor with the CIS PRO+ body-worn processor in the COMBI 40/COMBI 40+ implant system. Speech tests were performed in 46 experienced subjects in two test sessions approximately 4 weeks apart. Subjects were switched over from the CIS PRO+ to the TEMPO+ in the first session and used only the TEMPO+ in the time between the two sessions. Speech tests included monosyllabic word tests and sentence tests via the telephone. An adaptive noise method was used to adjust each subject's scores to approximately 50%. Additionally, subjects had to complete a questionnaire based on their 4 weeks of experience with the TEMPO+. The speech test results showed a statistically significant improvement in the monosyllabic word scores with the TEMPO+. In addition, in the second session, subjects showed a significant improvement when using the telephone with the TEMPO+, indicating some learning in this task. In the questionnaire, the vast majority of subjects found that the TEMPO+ allows equal or better speech understanding and rated the sound quality of the TEMPO+ higher. All these objective and subjective results indicate the superiority of the TEMPO+ and are mainly attributed to a new coding strategy called CIS+ and its implementation in the TEMPO+. In other words, based on the results of this study, it appears that after switching over from the CIS PRO+ to the TEMPO+, subjects are able to maintain or even improve their own speech understanding capability.


Subject(s)
Cochlear Implants , Deafness/therapy , Adult , Aged , Cochlear Implants/standards , Deafness/etiology , Equipment Design , Female , Humans , Male , Middle Aged , Psychometrics , Speech Discrimination Tests , Speech Perception , Surveys and Questionnaires
13.
Am J Otol ; 21(6): 793-8, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11078065

ABSTRACT

HYPOTHESIS: This study aimed to analyze the localization and distribution of vessels and of these angiogenic growth factors: basic fibroblast growth factor (FGF-2), transforming growth factor-alpha (TGF-alpha), transforming growth factor-beta1 (TGF-beta1), and vascular endothelial growth factor (VEGF) in middle ear cholesteatoma in comparison with normal middle ear mucosa and auditory meatal skin. BACKGROUND: Angiogenesis is particularly important in many normal and pathologic processes, including wound healing and inflammation. Because proliferating tissues require an enhanced blood supply, angiogenesis appears to be a prerequisite for the expansion of cholesteatoma. METHODS: The expression of FGF-2, TGF-alpha, TGF-beta1, and VEGF was studied by immunohistochemistry. The amount of vessels (collagen type IV staining) was determined by an automatic imaging analyzing system. RESULTS: The results showed an altered expression and distribution of VEGF, FGF-2, TGF-alpha, and TGF-beta1 in cholesteatoma in relation to middle ear mucosa and auditory meatal skin. The results were consistent with rapidly growing, activated keratinocytes and stromal cells. Vascularization within the perimatrix of cholesteatoma showed a 4.3-fold increase compared with middle ear mucosa and a twofold increase compared with ear canal skin. An increase of 3.2- to 4-fold in the number of vessels was observed. A close relationship was seen between the density of capillaries, degree of inflammation, and expression of the angiogenic factors investigated, and an increased number of microvessels in cholesteatoma tissue. CONCLUSIONS: Angiogenesis enables and supports the sustained migration of keratinocytes into the middle ear cavity. Therefore, it is a pivotal factor in the destructive behavior of middle ear cholesteatoma.


Subject(s)
Angiogenesis Inducing Agents/metabolism , Cholesteatoma, Middle Ear/metabolism , Cholesteatoma, Middle Ear/pathology , Antibodies, Monoclonal/metabolism , Cell Movement/physiology , Culture Techniques , Endothelial Growth Factors/metabolism , Fibroblast Growth Factor 2/metabolism , Immunohistochemistry , Lymphokines/metabolism , Transforming Growth Factor alpha/metabolism , Transforming Growth Factor beta/metabolism , Transforming Growth Factor beta1 , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
15.
Laryngorhinootologie ; 79(4): 207-12, 2000 Apr.
Article in German | MEDLINE | ID: mdl-10838684

ABSTRACT

BACKGROUND: The follow-up of squamous cell carcinomas of the head and neck is often challenging. Due to tissue alteration and anatomic changes after primary treatment or submucosal tumor growth, recurrences are sometimes detected very late. The tumor marker SCC-Antigen (SCC-Ag) may provide additional information for early detection of such tumor recurrences. PATIENTS: Serum levels of SCC-Ag in 578 patients with primary squamous cell carcinomas of the head and neck were assayed by SCC-RIA and IMx-SCC before treatment and every 2-3 months during follow-up. During the observation period of 30-84 (mean 50) months, 179 recurrences were verified by histologic examination. RESULTS: Seventy-seven patients (43%) with tumor recurrence showed elevated serum levels of SCC-Ag (< 2.0 ng/ml). Fifty-eight (32%) of them exhibited elevated levels of SCC-Ag up to 11 months (mean 6.1 months) prior to histopathologic diagnosis. This mainly became evident in 48 (83%) patients whose SCC-Ag serum levels were elevated before treatment. CONCLUSION: Use of SCC-Antigen in head and neck tumors follow-up can provide early evidence of almost one third of all recurrences of squamous cell carcinomas of the head and neck. For clinical purposes, we recommend an initial analysis of the SCC-Ag serum level in every patient with primary squamous cell carcinoma of the head and neck. The SCC levels of all SCC positive patients should be closely monitored. Elevated SCC should be regarded as a potential early sign for recurrence and therefore indicates the need for intensified follow-up. Depending on the individual situation this should include ultrasonography, CT, MRI and especially frequent endoscopy in general anesthesia with multiple biopsies of suspicious regions.


Subject(s)
Antigens, Neoplasm/blood , Biomarkers, Tumor , Carcinoma, Squamous Cell/diagnosis , Head and Neck Neoplasms/diagnosis , Neoplasm Recurrence, Local/diagnosis , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Immunoassay/methods , Male , Middle Aged , Radioimmunoassay , Sensitivity and Specificity , Serpins/analysis , Time Factors
16.
Int J Pediatr Otorhinolaryngol ; 49 Suppl 1: S81-6, 1999 Oct 05.
Article in English | MEDLINE | ID: mdl-10577781

ABSTRACT

Cholesteatoma in children is generally considered to be more aggressive and destructive than in adults. Each otologic surgeon has experienced widely extended cholesteatomas in children with large pneumatized mastoid processes. In this paper, we want to present clinical and experimental observations which imply that the destructive potential in children is similar to that in adults. Factors and observations that have led to the assumption that cholesteatoma in children is more aggressive will be discussed. Based on our experience and the literature, we tried to distill the current and leading thoughts concerning this intriguing entity.


Subject(s)
Cholesteatoma, Middle Ear/pathology , Adolescent , Adult , Child , Child, Preschool , Cholesteatoma, Middle Ear/complications , Cholesteatoma, Middle Ear/metabolism , Chronic Disease , Ear Canal/pathology , Epidermal Growth Factor/analysis , Fibroblast Growth Factor 2/analysis , Humans , Immunohistochemistry , Infant , Ki-67 Antigen/analysis , Otitis Media, Suppurative/complications , Skin/chemistry , Skin/pathology , Transforming Growth Factor alpha/analysis
17.
Laryngorhinootologie ; 78(2): 103-6, 1999 Feb.
Article in German | MEDLINE | ID: mdl-10226995

ABSTRACT

The paper gives an overview on postoperative treatment after ear surgery, especially tympanoplastic, mastoid-surgery and stapes-surgery. Suggestions for treatment are given according to the different post-operative stages and situations. Careful cleaning of the ear canal, using the operative microscope, removal of debris, granulations and polyp and drying of the canal are most important.


Subject(s)
Ear/surgery , Postoperative Care/methods , Humans
18.
Laryngorhinootologie ; 77(10): 541-6, 1998 Oct.
Article in German | MEDLINE | ID: mdl-9842516

ABSTRACT

BACKGROUND: In diagnostic imaging of the paranasal sinuses, the A-mode technique is increasingly being substituted by B-mode ultrasonography. To assess the value of B-mode sonography we compared in a double-blind study computed tomography with our ultrasound findings. PATIENTS AND METHODS: Seventy-eight patients were examined by CT and subsequently by ultrasound, two-thirds before endonasal surgery and one-third for diagnosis of serious facial pain and swelling. RESULTS: Among 114 pathological maxillary sinus tomograms, 83 findings could also be diagnosed by ultrasound (sensitivity 72.8%). In the frontal sinuses only 12 of 52 of pathological findings could be detected (23.1%) and only 9 of 80 in the frontal ethmoid (11.3%). Except for circumscribed polyps and moderate general swelling of the mucosa, the detection rate by sonography was 97.4% for the maxillary sinuses, 31.5% for the frontal and 18% for the ethmoid sinuses. CONCLUSIONS: Ultrasound usually only demonstrates the presence of absence or unspecific findings. Differential diagnosis between tumors and sinusitis is generally difficult. The healthy individual is correctly assessed as healthy due to the total reflection of the air-filled healthy sinus. According to our findings ultrasound has a certain value in the diagnosis of maxillary sinuses. It can be used to obtain a preliminary diagnosis and as a screening method although a negative result never excludes a disease of the sinuses. As it does not involve radiation exposure, ultrasonography can be recommended as first step in diagnosis for children, pregnant women, and young women especially in acute sinusitis, because in acute sinusitis the maxillary sinuses are generally affected.


Subject(s)
Paranasal Sinus Diseases/diagnosis , Tomography, X-Ray Computed , Ultrasonography , Adolescent , Adult , Aged , Aged, 80 and over , Child , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Paranasal Sinus Neoplasms/diagnosis , Pregnancy , Sensitivity and Specificity , Sinusitis/diagnosis
19.
HNO ; 45(8): 630-5, 1997 Aug.
Article in German | MEDLINE | ID: mdl-9378670

ABSTRACT

The development of a middle ear cholesteatoma is usually associated with chronic inflammation and displacement of the mucosa present by the invading squamous epithelium. To analyze the clinically different behaviors of both epithelia, we used immunohistochemical methods to study the distribution and expression of interleukin-1 (Il-1), transforming growth factor-alpha (TGF-alpha), epidermal growth factor (EGF), epidermal growth factor-receptor (EGF-R), the proliferation marker MIB 1, c-myc proto-oncogene product and activation marker 4F2. Results stromal that keratinocytes in a cholesteatoma exhibited a much higher activation and proliferation rate when compared to middle ear mucosa cells. Middle ear epithelial cells showed no immunoreactivity for TGF-alpha, EGF-R, Il-1 and c-myc in contrast to the markedly positive immunoreactivity found in cholesteatoma matrix. The local release of cytokines and growth factors, such as TGF-alpha, EGF and Il-1 by inflammatory cells seems to be an important factor for the hyper-proliferative behavior of cholesteatoma epithelium. Our findings could contribute to the pathogenesis of middle ear cholesteatoma and give a possible explanation for the sustained progression of its growth leading to displacement of the middle ear mucosa.


Subject(s)
Cholesteatoma, Middle Ear/pathology , Cytokines/physiology , Growth Substances/physiology , Biomarkers/analysis , Cell Division/physiology , Ear, Middle/pathology , Epidermal Growth Factor/analysis , Epithelium/pathology , ErbB Receptors/analysis , Humans , Immunoenzyme Techniques , Interleukin-1/analysis , Keratinocytes/pathology , Ki-67 Antigen/analysis , Mucous Membrane/pathology , Proto-Oncogene Mas , Proto-Oncogene Proteins c-myc/analysis , Transforming Growth Factor alpha/analysis
20.
Ann Otol Rhinol Laryngol ; 105(10): 804-10, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8865776

ABSTRACT

We investigated the distribution of basement membrane zone (BMZ) components collagen type IV, collagen type VII, and fibronectin in human middle ear cholesteatoma, auditory meatal skin, and middle ear mucosa using both immunohistochemical and ultrastructural methods. Collagen type IV immunoreactivity of skin and middle ear mucosa is continuous in the BMZ, whereas cholesteatoma frequently showed absent immunoreactivity or focal discontinuities. Collagen type VII immunoreactivity is detected similarly within the BMZ of cholesteatoma and skin. Fibronectin immunoreactivity is observed within the dermoepithelial junction of skin and middle ear mucosa. In cholesteatoma, however, fibronectin immunoreactivity is markedly increased within the extrinsic BMZ and the subepithelial connective tissue. The ultrastructural arrangement of the BMZ of cholesteatoma is like that of skin; however, it exhibits distinct alterations of the lamina fibroreticularis and lamina densa. Our results outline cholesteatoma as a disease with disturbed cell matrix interactions analogous to those of wound reepithelialization.


Subject(s)
Cholesteatoma, Middle Ear/metabolism , Cholesteatoma, Middle Ear/pathology , Ear, Middle/metabolism , Ear, Middle/ultrastructure , Basement Membrane/metabolism , Basement Membrane/ultrastructure , Collagen/analysis , Extracellular Matrix/metabolism , Extracellular Matrix/ultrastructure , Fibronectins/analysis , Humans , Microscopy, Electron , Mucous Membrane/metabolism , Mucous Membrane/ultrastructure , Skin/metabolism , Skin/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...